DVS SR

DRUG4 trials

Sponsors

Wyeth is now a wholly owned subsidiary of Pfizer, Pfizer

Conditions

Depressive Disorder, MajorDiabetic NeuropathiesMajor Depressive DisorderPain

Phase 3

Study Evaluating Desvenlafaxine Succinate Sustained-release (DVS SR) in Adult Outpatients With Pain Associated With Diabetic Peripheral Neuropathy

TerminatedNCT00283842

Wyeth is now a wholly owned subsidiary of PfizerDiabetic Neuropathies, Pain

Start: 2006-03-31End: 2008-06-30Updated: 2011-10-24

Paroxetine-referenced Study Evaluating Three Doses of DVS SR in Outpatients With MDD

CompletedNCT00445679

Wyeth is now a wholly owned subsidiary of PfizerDepressive Disorder, Major

Start: 2007-07-31End: 2009-02-28Updated: 2013-11-04

A 6-Month Open-Label Extension Study to the B2061014 Study to Evaluate the Safety, Tolerability and Efficacy of DVS SR in the Treatment of Children and Adolescents With MDD

CompletedNCT01371721

PfizerMajor Depressive Disorder

Start: 2012-02-29End: 2015-10-31Updated: 2017-02-08

A 6-Month Extension Study To The B2061032 Study To Evaluate The Safety, Tolerability, And Efficacy Of DVS SR In The Treatment Of Child And Adolescent Outpatients With MDD

CompletedNCT01371708

PfizerMajor Depressive Disorder

Start: 2012-02-02End: 2016-04-22Updated: 2017-07-27

Related Papers

Clinical experience with desvenlafaxine in treatment of pain associated with diabetic peripheral neuropathy.

2014-06-2327 citations